About Medglobe
Medglobe is a Healthcare company based in India. Manufacturing and marketing of pharmaceutical formulations in domestic markets. The company has 57 employees. Its Indian entity Medglobe Therapeutics Limited reported revenue of ₹21.04 Cr. Medglobe offers products and services including Tablets and Capsules. Its focus areas include Personal Care, Derma Products, Skin Care Formulations and Pharmaceuticals.
Company details
MEDGLOBE THERAPEUTICS LIMITED was incorporated under the Companies Act in 2005 at Hyderabad and is engaged in the manufacturing and marketing of pharmaceutical formulations. Manufacturing facilities are maintained in Bhagwanpur, Roorkee, Uttarakhand, providing a competitive advantage in the sector. A diverse range of products, including tablets, capsules, syrups, and derma care medicines, is offered under one roof, covering general, infertility, pediatric, and gastro segments. The company supports the production of over 450 formulations in various batch sizes, with DCGI-approved molecules being utilized to meet market demands. Operations are rooted in Hyderabad, with additional presence in Delhi for contacts.
- Headquarters India
- Employees 57
- SectorsHealthcare
- Email••••••••
- Legal Name Medglobe Therapeutics Limited
- Date of Incorporation 24 Apr, 2006
- Jurisdiction Delhi, India
- Annual Revenue₹21.04 Cr
FY 2023 · +73% YoY
- Net Profit₹1.05 Cr
FY 2023 · 5% margin
- EBITDA₹1.97 Cr
FY 2023 · 9% margin
- Employee Count57
Associated legal entities of Medglobe
Medglobe operates through Medglobe Therapeutics Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medglobe Therapeutics Limited CIN U24239DL2006PLC368703 | Active | 24 Apr 2006 | Delhi, Delhi | ₹21.0 Cr | 57 | 3 | View details |
Products & Services of Medglobe
Medglobe offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are manufactured for various uses, including general and specialized medicines, as part of the company's product range.
Capsules are produced for segments like infertility and pediatric care, forming a key part of the offered formulations.
Board of directors of Medglobe Therapeutics Limited (Medglobe)
Medglobe Therapeutics Limited is the primary company behind Medglobe. The board of Medglobe Therapeutics Limited currently have 3 directors; the longest-serving is Anuj Kumar Garawal, appointed in 2019. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anuj Kumar Garawal DIN 08262603 | Director | 03 Jan 2019 | 7 yrs 9 mo | Medglobe Therapeutics Limited |
| Amit Singh DIN 05167723 | Director | 03 Jan 2019 | 7 yrs 9 mo | Medglobe Therapeutics Limited |
| Varun Singh DIN 05167750 | Director | 05 Mar 2019 | 7 yrs 7 mo | Medglobe Therapeutics Limited |
Financials of Medglobe
Figures of Medglobe Therapeutics Limited, the primary company behind Medglobe, for FY 2023. Revenue was ₹21.04 Cr (+73% year on year). Net profit was ₹1.05 Cr (5% margin). EBITDA was ₹1.97 Cr (9% margin). Revenue has grown at a compounded annual rate of +99% over three years and +19% over five years.
- ₹21.04 CrRevenue · FY 2023 · +73% YoY
- ₹1.05 CrNet profit · 5% margin
- ₹1.97 CrEBITDA · 9% margin
- ₹2.85 CrPaid-up capital
- 57Employees (provident fund records)
- +99%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medglobe Therapeutics Limited are on its company page.
Detailed financial statements for Medglobe
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Dermatology
2 companies that operate in the same segment as Medglobe (Dermatology) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | ||||
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medglobe
Medglobe is headquartered in India.
Medglobe has 57 employees.
The primary company behind Medglobe, Medglobe Therapeutics Limited, reported revenue of ₹21.04 Cr for FY 2023, up 73% year on year.
MEDGLOBE THERAPEUTICS LIMITED was incorporated under the Companies Act in 2005 at Hyderabad and is engaged in the manufacturing and marketing of pharmaceutical formulations. Manufacturing facilities are maintained in Bhagwanpur, Roorkee, Uttarakhand, providing a competitive advantage in the sector. A diverse range of products, including tablets, capsules, syrups, and derma care medicines, is offered under one roof, covering general, infertility, pediatric, and gastro segments. The company supports the production of over 450 formulations in various batch sizes, with DCGI-approved molecules being utilized to meet market demands. Operations are rooted in Hyderabad, with additional presence in Delhi for contacts.
Medglobe offers Tablets and Capsules.
Medglobe operates through Medglobe Therapeutics Limited.
The legal entities of Medglobe currently have 3 directors, including Varun Singh, Anuj Kumar Garawal, Amit Singh.